Howard L. Adler, MD

Dr. Adler has been providing urologic care to the Long Island community for 25 years. He enjoys the longstanding relationships he has with his patients and strives to make sure his patients always feel comfortable asking questions whether during office visits or anytime thereafter. He finds the field of Urology is extremely exciting and has stated that managing patients in several areas including the prevention of BPH as well as curing cancer is very rewarding.

NY Top Docs: 2018, 2019, 2020
Stony Brook Medicine Community Service Award: 2007-2012, 2014-2018, 2020
Proclamation from Suffolk County Legislator William Lindsay in Recognition of Prostate Cancer Screenings: 2018
Castle Connolly Regional Top Doctors: 2019-2024
Newsday - Top Doctors on Long Island: 2018, 2019, 2023
Top Doctors New York Metro Area: 2018-2020, 2022

Prostate cancer, BPH, prostate cancer screening.

Primary Investigator: URO-008 Registry, "Long-Term Prospective Registry to Evaluate Treatment Decisions and Clinical Outcomes in Patients with Favorable Intermediate Risk Localized Prostate Cancer Following Cell Cycle Progression (CCP) Testing (Prolaris® Test)"
Sub-Investigator: NRG-GU002, "Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy with or without Adjuvant Docetaxel" RTOG-0924, "Androgen Deprivation Therapy and High Dose Radiotherapy with or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial " PRIORITY Registry, "Prospective Validation of Prostate Biomarkers for Repeat Biopsy: The Priority Study"

• Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer.
  
  Paris PL | Kobayashi Y | Zhao Q | Zeng W | Sridharan S | Fan T | Adler HL | Yera ER | Zarrabi MH | Zucker S | Simko J | Chen WT | Rosenberg J
  Cancer letters
  2009 May 18
  
  
• Diagnosis of bladder cancer with microelectromechanical systems-based cystoscopic optical coherence tomography.
  
  Ren H | Waltzer WC | Bhalla R | Liu J | Yuan Z | Lee CS | Darras F | Schulsinger D | Adler HL | Kim J | Mishail A | Pan Y
  Urology
  2009 Dec
  
  
• Wilm's tumor during pregnancy: report of laparoscopic removal and review of literature.
  
  Rehman J | Chughtai B | Guru K | Khan SA | Adler HL | Miller F
  The Canadian journal of urology
  2008 Aug
  
  
• A percutaneous subcostal approach for intercostal stones.
  
  Rehman J | Chughtai B | Schulsinger D | Adler H | Khan SA | Samadi D
  Journal of endourology / Endourological Society
  2008 Mar
  
  
• Deficits in urological knowledge among medical students and primary care providers: potential for impact on urological care.
  
  Mishail A | Shahsavari M | Kim J | Welliver RC Jr | Vemulapalli P | Adler HL
  The Journal of urology
  2008 Nov
  
  
• Are patients aware of the association between smoking and bladder cancer?
  
  Nieder AM | John S | Messina CR | Granek IA | Adler HL
  The Journal of urology
  2006 Dec
  
  
• Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity.
  
  Botchkina GI | Kim RH | Botchkina IL | Kirshenbaum A | Frischer Z | Adler HL
  Clinical cancer research : an official journal of the American Association for Cancer Research
  2005 May 1
  
  
• Membrane type 1-matrix metalloproteinase promotes human prostate cancer invasion and metastasis.
  
  Cao J | Chiarelli C | Kozarekar P | Adler HL
  Thrombosis and haemostasis
  2005 Apr
  
  
• Intratesticular adenomatoid tumor radiographically mimicking a primary testicular malignancy.
  
  Adler HL | Haddad JL | Wheeler TM | Kim ED
  TheScientificWorldJournal
  2004 Jun 7
  
  
• Prostate cancer cell adhesion to bone marrow endothelium: the role of prostate-specific antigen.
  
  Romanov VI | Whyard T | Adler HL | Waltzer WC | Zucker S
  Cancer research
  2004 Mar 15
  
  
• Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy.
  
  Miles BJ | Shalev M | Aguilar-Cordova E | Timme TL | Lee HM | Yang G | Adler HL | Kernen K | Pramudji CK | Satoh T | Gdor Y | Ren C | Ayala G | Wheeler TM | Butler EB | Kadmon D | Thompson TC
  Human gene therapy
  2001 Nov 1
  
  
• Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy.
  
  Shariat SF | Bergamaschi F | Adler HL | Nguyen C | Kattan MW | Wheeler TM | Slawin KM
  Urology
  2000 Sep 1
  
  
• Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer.
  
  Shalev M | Kadmon D | Teh BS | Butler EB | Aguilar-Cordova E | Thompson TC | Herman JR | Adler HL | Scardino PT | Miles BJ
  The Journal of urology
  2000 Jun
  
  
• In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.
  
  Herman JR | Adler HL | Aguilar-Cordova E | Rojas-Martinez A | Woo S | Timme TL | Wheeler TM | Thompson TC | Scardino PT
  Human gene therapy
  1999 May 1
  
  
• Bilateral anterior ischemic optic neuropathy and branch retinal artery occlusion after radical prostatectomy.
  
  Williams GC | Lee AG | Adler HL | Coburn A | Rosas AL | Tang RA | Scardino PT
  The Journal of urology
  1999 Oct
  
  
• Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma.
  
  Adler HL | McCurdy MA | Kattan MW | Timme TL | Scardino PT | Thompson TC
  The Journal of urology
  1999 Jan
  
  
• Renal cell carcinoma and situs inversus viscerum.
  
  Adler HL | Lerner SP
  The Journal of urology
  1998 Dec
  
  
• Extraperitoneal endoscopic pelvic lymph node dissection: a review of 125 patients.
  
  Raboy A | Adler H | Albert P
  The Journal of urology
  1997 Dec
  
  
• The role of urodynamics in the evaluation of voiding dysfunction in men after cerebrovascular accident.
  
  Nitti VW | Adler H | Combs AJ
  The Journal of urology
  1996 Jan